Cancer of Esophagus: Clinical Trials

4 trials for Cancer of Esophagus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 unknown. 4 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Unknown 1
Phase 11Unknown 1

Follow Cancer of Esophagus: new trials by email Literature Review of Cancer of Esophagus trials Research Report on Cancer of Esophagus

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
CBP-1019 - Cancer, Breast, Cancer, Lung
Phase 1 / Phase 2UnknownCoherent Biopharma (Hefei) Co., Ltd.2602023-03-142024-08-26
Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer
Temozolomide, Temozolomide 50mg/m2/day, Temozolomide 3 month - Adenocarcinoma - GEJ, Cancer of Esophagus
Phase 2CompletedUniversity of Southampton132021-09-282026-05-18
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
Pembrolizumab, Tadalafil - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Phase 2CompletedUniversity of California, San Diego72020-04-072026-02-12
Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer
Irinotecan (drug), Taxotere (drug), Radiotherapy (procedure) - Esophageal Cancer, Cancer of the Esophagus
Phase 2CompletedUniversity of Alabama at Birmingham252002-01-012023-05-25

Narrower conditions

Esophageal Neoplasms (4)  ·  Neoplasms (2)  ·  Breast Neoplasms (1)  ·  Carcinoma (1)  ·  Colonic Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Mouth Neoplasms (1)  ·  Neoplasm Metastasis (1)  ·  Pancreatic Neoplasms (1)  ·  Parkinson Disease 4, Autosomal Dominant Lewy Body (1)  ·  Pyridoxine-dependent epilepsy (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Digestive System Diseases (4)  ·  Digestive System Neoplasms (4)  ·  Esophageal Diseases (4)  ·  Gastrointestinal Diseases (4)  ·  Gastrointestinal Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Head and Neck Neoplasms (3)  ·  Neoplasms (2)  ·  Breast Diseases (1)  ·  Carcinoma, Squamous Cell (1)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Intestinal Diseases (1)

Interventions

Docetaxel (1)  ·  Esophagectomy (1)  ·  Injections (1)  ·  Irinotecan (1)  ·  Nivolumab (1)  ·  Pharmaceutical Preparations (1)  ·  Radiotherapy (1)  ·  Tadalafil (1)  ·  Temozolomide (1)  ·  pembrolizumab (1)

Sponsors

Coherent Biopharma (Hefei) Co., Ltd. (1)  ·  University of Alabama at Birmingham (1)  ·  University of California, San Diego (1)  ·  University of Southampton (1)

Countries

United States (3)  ·  China (1)  ·  United Kingdom (1)

Top investigators

Elizabeth Smyth (1)  ·  James A. Posey, M.D. (1)  ·  Joseph Califano (1)  ·  Lin Shen, MD (1)